GET THE APP
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Select your language of interest to view the total content in your interested language
Dr. Srinivasan Shanmugam received his Ph.D. in Pharmaceutical Science from the College of Pharmacy, Yeungnam University in 2010. During his doctoral studies, his research was on liposomes, niosomes, and chemical enhancers for topical delivery and self-emulsifying drug delivery systems (SNEDDS) for oral delivery. He received his MS in Pharmaceutical Sciences in the same university in the year of 2007, and his research focus during this period was on mixed micellar nanoparticles for parenteral and liposomes for topical delivery. His undergraduate major was Pharmacy (Bachelor of Phramacy) and received his degree in the year of 1999 with research focus on “Endothelin Receptors.” Right after undergraduate degree, he gained hands on experience in manufacturing of solid/liquid dosage formulations by working in pharmaceutical companies for about five years. Currently, Dr. Shanmugam is a Project Leader (Principal Scientist) in Formulation R&D Division of Hanmi Pharm. Co. Ltd., South Korea.
Drug Delivery Systems: ïÂÂ Conventional systems (tablets, capsules, emulsions, and suspensions) ïÂÂ Novel delivery systems (lipid formulations, micro/nano emulsions/self-emulsifying, micelles, liposomes/niosomes/cubosomes, multiparticulate, and pulsatile/targeted delivery ssytems). Drug Delivery Techniques: ïÂÂ Dissolution/solubility/stability enhancement ïÂÂ Bioavailability enhancement (oral/lymphatic/transdermal) ïÂÂ Perrmeability enhancement (oral/topical/transdermal) Drug Delivery Technologies: ïÂÂ Modified release (sustained/delayed/controlled/pulsatile/targeted) ïÂÂ Spray/freeze drying, and fluid bed drying
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals